Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.
Lutfiye Ozlem AtayEsen SakaÜmit Özgür AkdemirEzgi YetimErdem BalcıEthem Murat ArsavaMehmet Akif TopcuogluPublished in: Current Alzheimer research (2023)
Integrated use of structural, metabolic, molecular (Aβ) and perfusion (CBF) parameters contribute to the discrimination of SCD, aMCI, and ADD.